Changliang Shan

Dr. Changliang Shan

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Cancer Cell
Verified
Journal Article
Closed access
THTaro Hitosugi
Taro Hitosugi
LZLu Zhou
Lu Zhou
SEShannon Elf
Shannon Elf
JFJun Fan
Jun Fan
HKHee-Bum Kang
Hee-Bum Kang
JCJing Chen
Jing Chen

9 November 2015 in Nature Chemistry
Verified
Journal Article
Closed access
PDF file
JWJing Wang
Jing Wang
CLCheng Luo
Cheng Luo
CSChangliang Shan
Changliang Shan
QYQiancheng You
Qiancheng You
JLJunyan Lu
Junyan Lu
CHChuan He
Chuan He

1 February 2014 in Molecular Cell
Verified
Journal Article
Closed access
JFJun Fan
Jun Fan
CSChangliang Shan
Changliang Shan
HKHee-Bum Kang
Hee-Bum Kang
SEShannon Elf
Shannon Elf
JXJianxin Xie
Jianxin Xie
JCJing Chen
Jing Chen

19 October 2015 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
RLRuiting Lin
Ruiting Lin
SEShannon Elf
Shannon Elf
CSChangliang Shan
Changliang Shan
HKHee-Bum Kang
Hee-Bum Kang
QJQuanjiang Ji
Quanjiang Ji
JCJing Chen
Jing Chen
The oxidative pentose phosphate pathway (PPP) contributes to tumour growth, but the precise contribution of 6-phosphogluconate dehydrogenase (6PGD), the third enzyme in this pathway, to tumorigenesis remains unclear. We found that suppression of 6PGD decreased lipogenesis and RNA biosynthesis and elevated ROS levels in cancer cells, attenuating cell proliferation and tumour growth. 6PGD-mediated production of ribulose-5-phosphate (Ru-5-P) inhibits AMPK activation by disrupting the active LKB1 complex, thereby activating acetyl-CoA carboxylase 1 and lipogenesis. Ru-5-P and NADPH are thought to be precursors in RNA biosynthesis and lipogenesis, respectively; thus, our findings provide an additional link between the oxidative PPP and lipogenesis through Ru-5-P-dependent inhibition of LKB1–AMPK signalling. Moreover, we identified and developed 6PGD inhibitors, physcion and its derivative S3, that effectively inhibited 6PGD, cancer cell proliferation and tumour growth in nude mice xenografts without obvious toxicity, suggesting that 6PGD could be an anticancer target.

1 August 2015 in Molecular Cell
Verified
Journal Article
Closed access
HKHee-Bum Kang
Hee-Bum Kang
JFJun Fan
Jun Fan
RLRuiting Lin
Ruiting Lin
SEShannon Elf
Shannon Elf
QJQuanjiang Ji
Quanjiang Ji
JCJing Chen
Jing Chen

1 August 2014 in Molecular Cell
Verified
Journal Article
Closed access
CSChangliang Shan
Changliang Shan
SEShannon Elf
Shannon Elf
QJQuanjiang Ji
Quanjiang Ji
HKHee-Bum Kang
Hee-Bum Kang
LZLu Zhou
Lu Zhou
JCJing Chen
Jing Chen